Misoprostol is effective treatment for patients with severe chronic constipation
- 93 Downloads
To assess the efficacy of misoprostol in the treatment of patients with severe chronic constipation, nine such patients were enrolled in a double-blind, randomized, crossover study of misoprostol (1200 µg/day) or placebo, that lasted three weeks. During this period each patient received the drug for one week and placebo for another with a week washout period in between. A colonic transit study, using radiopaque markers, was performed during each of the treatment weeks, while the number of stools and their total weight was recorded by each patient for the appropriate periods. Colonic transit time was significantly and consistently decreased by misoprostal compared to placebo [66 hr±10.2 vs 109.4 hr±8.1 (P=0.0005)]. Misoprostrol significantly increased the total stool weight per week [976.5 g±288.8 vs 434.6 g±190.5 (P=0.001)] and also significantly increased the number of stools per week compared to placebo [6.5±1.3 vs 2.5±0.11 (P=0.01)]. The incidence of abdominal pain was similar in both groups. We concluded that misoprostol, during a short trial period, proved effective in increasing the frequency and weight of bowel movements and decreasing colonic transit time in patients with severe chronic constipation. It may be used as a therapeutic measure to treat such patients.
Key wordsmisoprostol constipation
Unable to display preview. Download preview PDF.
- 1.Monk JP, Clissold SP: Misoprostol. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of peptic ulcer disease. Drugs 33:1–30, 1987Google Scholar
- 3.Robert A: Antisecretory, antiulcer, cytoprotective and diarrhoegenic properties of prostaglandins.In Advances in Prostaglandin and Thromboxane Research, Vol 2. B Samuelsson, JR Vane (eds). New York, Raven Press, 1976, pp 507–520Google Scholar
- 4.Gullikson GW, Pautsch W, Bianchi RG, Monroy M, Bauer R: Comparative effects of misoprostol and 16,16-dimethyl PGE2 on intestinal fluid transport and myoelectric spike activity in the dog. Dig Dis Sci 31:148S, 1986Google Scholar
- 10.Bennet A, Sanger GJ: Acid lipids: Prostaglandins.In Mediators and Drugs in Gastrointestinal Motility. G Bertaccini (ed). New York, Springer-Verlag, 1982, pp 219–248Google Scholar
- 19.Delvaux M, Staumont G, Fioramonti J, Bueno L, Frexinos J: Alterations of colonic motility after oral administration of prostaglandin E1 analogue misoprostol in man. J Gastrointest Motil 4:33–38, 1992Google Scholar
- 22.Lemli J, Lemmens L: Metabolism of sennosides and rhein in the rat. Pharmacol 20(Suppl 1):50–57, 1980Google Scholar